Company Profiles

driven by the PitchBook Platform

Antegrin Therapeutics

Description

Developer of compounds to treat lung disease. The company is developing compounds for the treatment of human fibrotic disease, initially targeting idiopathic pulmonary fibrosis, a progressive life-threatening condition.

2012

Founded

M&A

Status

Merger of Eq.

Latest Deal Type

$696k

Total Amount Raised

Description

Developer of compounds to treat lung disease. The company is developing compounds for the treatment of human fibrotic disease, initially targeting idiopathic pulmonary fibrosis, a progressive life-threatening condition.

Website:

www.antegrin.com

Ownership Status

Acquired/Merged

Financing Status

Formerly VC-Backed

Primary Industry

Therapeutic Devices

Other Industries

Other Healthcare

Primary Office

4320 Forest Park Avenue Suite 304 Saint Louis, MO 63108United States +1 (314) 932-4032
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Antegrin Therapeutics's full profile, request a free trial.

    Antegrin Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Antegrin Therapeutics Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Peter RuminskiCo-Founder & Scientific Advisor
    Robert Karr MDPresident, Chief Executive Officer & Board Member
    George Capps IIDirector, Business Development
    Rajesh Devraj Ph.DChairman
    Peter Ruminski Co-Founder & Scientific Advisor
    Robert Karr MD President, Chief Executive Officer & Board Member
    George Capps II Director, Business Development
    Rajesh Devraj Ph.D Chairman

    Antegrin Therapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    David Griggs Ph.DIndalo TherapeuticsCo-Founder & Board Member000 0000
    Michael Yeadon Ph.DSelfBoard Member000 0000
    Rajesh Devraj Ph.DSelfChairman000 0000
    Robert Karr MDSelfPresident, Chief Executive Officer & Board Member000 0000
    Thomas Cirrito Ph.DSelfBoard Member000 0000
    David Griggs Ph.D Co-Founder & Board Member Indalo Therapeutics
    Michael Yeadon Ph.D Board Member Self
    Rajesh Devraj Ph.D Chairman Self
    Robert Karr MD President, Chief Executive Officer & Board Member Self
    Thomas Cirrito Ph.D Board Member Self
    Request full access to PitchBook